Cooper Return on Investment 2010-2024 | COO
Current and historical return on investment (ROI) values for Cooper (COO) over the last 10 years.
| Cooper ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-07-31 |
$0.64B |
$10.52B |
6.21% |
| 2024-04-30 |
$0.60B |
$10.48B |
5.88% |
| 2024-01-31 |
$0.54B |
$10.42B |
5.31% |
| 2023-10-31 |
$0.53B |
$10.08B |
5.34% |
| 2023-07-31 |
$0.50B |
$10.04B |
5.08% |
| 2023-04-30 |
$0.49B |
$9.94B |
5.04% |
| 2023-01-31 |
$0.53B |
$9.96B |
5.51% |
| 2022-10-31 |
$0.51B |
$9.53B |
5.41% |
| 2022-07-31 |
$0.53B |
$9.43B |
5.87% |
| 2022-04-30 |
$0.49B |
$9.36B |
5.66% |
| 2022-01-31 |
$0.50B |
$9.27B |
6.10% |
| 2021-10-31 |
$0.51B |
$8.34B |
6.49% |
| 2021-07-31 |
$0.48B |
$7.97B |
6.80% |
| 2021-04-30 |
$0.45B |
$7.49B |
7.11% |
| 2021-01-31 |
$0.33B |
$7.40B |
5.89% |
| 2020-10-31 |
$0.31B |
$5.21B |
6.17% |
| 2020-07-31 |
$0.36B |
$5.09B |
7.21% |
| 2020-04-30 |
$0.43B |
$4.97B |
8.64% |
| 2020-01-31 |
$0.55B |
$4.97B |
10.99% |
| 2019-10-31 |
$0.55B |
$4.89B |
10.91% |
| 2019-07-31 |
$0.52B |
$5.04B |
10.23% |
| 2019-04-30 |
$0.50B |
$5.02B |
9.51% |
| 2019-01-31 |
$0.43B |
$5.11B |
7.90% |
| 2018-10-31 |
$0.40B |
$5.29B |
7.37% |
| 2018-07-31 |
$0.39B |
$5.48B |
7.44% |
| 2018-04-30 |
$0.39B |
$5.63B |
7.84% |
| 2018-01-31 |
$0.43B |
$5.53B |
9.32% |
| 2017-10-31 |
$0.43B |
$4.33B |
10.18% |
| 2017-07-31 |
$0.40B |
$4.27B |
9.65% |
| 2017-04-30 |
$0.39B |
$4.29B |
9.47% |
| 2017-01-31 |
$0.36B |
$4.02B |
8.88% |
| 2016-10-31 |
$0.32B |
$3.80B |
8.08% |
| 2016-07-31 |
$0.29B |
$4.15B |
7.29% |
| 2016-04-30 |
$0.24B |
$4.16B |
6.11% |
| 2016-01-31 |
$0.22B |
$3.94B |
5.79% |
| 2015-10-31 |
$0.24B |
$3.78B |
6.26% |
| 2015-07-31 |
$0.23B |
$3.76B |
6.14% |
| 2015-04-30 |
$0.28B |
$3.72B |
7.78% |
| 2015-01-31 |
$0.30B |
$3.82B |
8.81% |
| 2014-10-31 |
$0.31B |
$3.87B |
9.85% |
| 2014-07-31 |
$0.33B |
$2.98B |
11.66% |
| 2014-04-30 |
$0.33B |
$2.86B |
11.89% |
| 2014-01-31 |
$0.32B |
$2.76B |
11.86% |
| 2013-10-31 |
$0.31B |
$2.73B |
11.51% |
| 2013-07-31 |
$0.32B |
$2.65B |
12.34% |
| 2013-04-30 |
$0.31B |
$2.63B |
11.81% |
| 2013-01-31 |
$0.29B |
$2.63B |
11.54% |
| 2012-10-31 |
$0.28B |
$2.56B |
11.63% |
| 2012-07-31 |
$0.27B |
$2.55B |
11.49% |
| 2012-04-30 |
$0.25B |
$2.31B |
10.72% |
| 2012-01-31 |
$0.24B |
$2.31B |
10.48% |
| 2011-10-31 |
$0.23B |
$2.27B |
9.91% |
| 2011-07-31 |
$0.22B |
$2.29B |
9.74% |
| 2011-04-30 |
$0.22B |
$2.33B |
9.78% |
| 2011-01-31 |
$0.20B |
$2.31B |
8.95% |
| 2010-10-31 |
$0.19B |
$2.26B |
8.45% |
| 2010-07-31 |
$0.17B |
$2.22B |
7.47% |
| 2010-04-30 |
$0.15B |
$2.24B |
6.65% |
| 2010-01-31 |
$0.15B |
$2.28B |
6.71% |
| 2009-10-31 |
$0.15B |
$2.31B |
6.55% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$18.348B |
$3.895B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
